Q2 2025 Earnings Estimate for UnitedHealth Group Incorporated (NYSE:UNH) Issued By Leerink Partnrs

UnitedHealth Group Incorporated (NYSE:UNH) – Equities research analysts at Leerink Partnrs dropped their Q2 2025 earnings estimates for UnitedHealth Group in a research report issued on Tuesday, October 15th. Leerink Partnrs analyst W. Mayo now anticipates that the healthcare conglomerate will post earnings per share of $7.47 for the quarter, down from their previous estimate of $7.61. The consensus estimate for UnitedHealth Group’s current full-year earnings is $27.68 per share. Leerink Partnrs also issued estimates for UnitedHealth Group’s Q3 2025 earnings at $7.51 EPS.

A number of other research firms also recently issued reports on UNH. Barclays boosted their price target on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Argus boosted their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Wells Fargo & Company lifted their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Robert W. Baird lifted their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Wednesday. One equities research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group has an average rating of “Buy” and a consensus price target of $615.16.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $571.30 on Thursday. The company’s 50 day simple moving average is $584.21 and its 200-day simple moving average is $532.84. The company has a market capitalization of $527.55 billion, a price-to-earnings ratio of 37.88, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. UnitedHealth Group has a 1 year low of $436.38 and a 1 year high of $608.63. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same period last year, the business earned $6.56 earnings per share. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year.

Institutional Trading of UnitedHealth Group

Several institutional investors and hedge funds have recently bought and sold shares of the business. Swedbank AB purchased a new position in UnitedHealth Group during the 1st quarter worth $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in UnitedHealth Group by 107.8% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock worth $1,141,113,000 after buying an additional 1,196,758 shares during the last quarter. Lone Pine Capital LLC purchased a new position in UnitedHealth Group during the 2nd quarter worth $480,903,000. Dimensional Fund Advisors LP grew its stake in shares of UnitedHealth Group by 30.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after purchasing an additional 880,183 shares during the period. Finally, Baillie Gifford & Co. grew its stake in shares of UnitedHealth Group by 1,125.4% during the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock worth $455,281,000 after purchasing an additional 821,050 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.47%. UnitedHealth Group’s dividend payout ratio (DPR) is 55.70%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.